CEO educational background and acquisition targets selection (With David Yin) Journal of Corporate Finance 52, 238-259, 2018.

Using hand-collected CEO education data of 3,574 CEOs over the period of 2000 to 2015, we document that CEOs are significantly more likely to acquire targets that are headquartered in those states where the CEOs received their undergraduate and graduate degrees. Education-state deals are larger, have higher completion rates, and exist with both public and private targets. Acquirers pay a lower target premium for education-state deals and the cumulative abnormal announcement returns are positive. The combined evidence suggests that education-state acquisitions are more likely to be driven by bidder CEO’s information advantage toward firms headquartered in the education state.

Hiring retiring-age CEOs​ (With David Yin) European Financial Management, forthcoming 

We document a stylized fact that more than 10% of S&P 1500 companies have hired a CEO who starts the job near or above the retirement age of 65 years old (Retiring CEOs). We find that, although hiring retiring CEOs on average has a negative impact due to the management deficiencies, they can bring valuable advisory benefits to firms when they are hired to resolve firm distress. Retiring CEOs receive lower compensation and they have a shorter tenure. Overall, evidence from this paper suggests that retiring CEOs can be beneficial to shareholders when they are hired for the right purpose. 

Working Papers

1. Firm reputation and the cost of bank debt (Job Market Paper) 

This paper examines whether firm reputation impacts borrowing costs and thus investment. Using unique data from Fortune’s Most Admired Companies surveys, I find that reputable borrowers enjoy lower borrowing costs and better loan contract terms. My identification strategy is based on propensity score matching, a regression discontinuity design, and clean reputation measures removing the impact of prior financial performance. Further evidence suggests that banks reward reputable firms with better contract terms because this reputation proxy contains incremental information on borrower future performance and credit risk. Last, firms increase capital expenditures and R&D after receiving the Most Admired designation, consistent with reputable firms exploiting their lower cost of capital and with reputation having real effects on firms’ investment policies.

  • American Finance Association Ph.D. Students Poster Session 

  • Financial Management Association Annual Meeting 

  • The University of Arizona (2019 Scheduled)

  • Southwestern Finance Association Annual Meeting (2019)

  • Eastern Finance Association Annual Meeting (2019)

2. Mergers, Product Prices, and Innovation: Evidence from the Pharmaceutical Industry​ (With Alice Bonaimé)

Using novel data from the pharmaceutical industry, we study the impact of mergers on product prices and innovation. Exploiting within-deal variation in product market consolidation, we show prices increase 2.4–3.5% more within drugs belonging to consolidating markets than within matched control drugs. Elevated prices persist for two years. Price increases are more pronounced within concentrated product markets and for acquisitions of drugs still in the pipeline. These findings are consistent with the effects of market power consolidation from mergers outweighing synergistic gains. Examination of trade-offs reveals these deals generate significant shareholder value but fail to spur meaningful innovation.

  • Midwest Finance Association (2020)

  • American Finance Association (2020)

  • Virginia Tech University 

  • Center for Management Innovations in Healthcare (CMIH) 2019 Fall Research Grant 

  • The University of Arizona (2019)

  • The University of Exeter (2019)

  • The University of Bristol (2019)